We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Size, Shape of Generics Should Be Similar to Brand Counterparts
FDA: Size, Shape of Generics Should Be Similar to Brand Counterparts
The FDA wants generics makers to design tablets and capsules to be similar in size and shape to their reference listed drug to ensure patient acceptance and compliance, according to final guidance issued Thursday.